Clinical Trials Logo

Clinical Trial Summary

Single arm pilot study to evaluate the safety and initial feasibility of the Neurolyser XR, a new portable high intensity focused ultrasound device, for noninvasive thermal ablation of medial nerve branches of painful lumbar facet joint/s


Clinical Trial Description

Study design: Prospective, single arm Timeline: six month enrollment period and 12 months follow-up period. Sites: The study will be conducted at McGill University. Study population: Ten adult patients diagnosed with facet related low back pain. Primary study objective: Safety and efficacy of the Neurolyser XR for the treatment of facet related low back pain. Safety would be evaluated by the incidence and severity of treatment related adverse events Efficacy would be evaluated by the changes in average pain score and Rolland Morris Disability Questionnaire between baseline and 6 months. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT03321344
Study type Interventional
Source FUSMobile Inc.
Contact
Status Completed
Phase N/A
Start date December 5, 2017
Completion date February 19, 2020